PL1791423T3 - Kompozycje i sposoby postępowania z hiperproliferacyjnymi zaburzeniami dermatologicznymi - Google Patents
Kompozycje i sposoby postępowania z hiperproliferacyjnymi zaburzeniami dermatologicznymiInfo
- Publication number
- PL1791423T3 PL1791423T3 PL04795060T PL04795060T PL1791423T3 PL 1791423 T3 PL1791423 T3 PL 1791423T3 PL 04795060 T PL04795060 T PL 04795060T PL 04795060 T PL04795060 T PL 04795060T PL 1791423 T3 PL1791423 T3 PL 1791423T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- management
- methods
- dermatological conditions
- hyperproliferative
- Prior art date
Links
- 230000003463 hyperproliferative effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/710,778 US7582314B2 (en) | 2003-12-03 | 2004-08-02 | Compositions and methods for the management of hyperproliferative dermatological conditions |
| PCT/US2004/033846 WO2006022762A1 (en) | 2004-08-02 | 2004-10-14 | Compositions and methods for the management of hyperproliferative dermatological conditions |
| EP04795060.5A EP1791423B1 (en) | 2004-08-02 | 2004-10-14 | Compositions and methods for the management of hyperproliferative dermatological conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1791423T3 true PL1791423T3 (pl) | 2013-09-30 |
Family
ID=35967805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04795060T PL1791423T3 (pl) | 2004-08-02 | 2004-10-14 | Kompozycje i sposoby postępowania z hiperproliferacyjnymi zaburzeniami dermatologicznymi |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1791423B1 (https=) |
| JP (1) | JP4820819B2 (https=) |
| CN (1) | CN101132693B (https=) |
| AU (1) | AU2004322710B2 (https=) |
| DK (1) | DK1791423T3 (https=) |
| ES (1) | ES2422893T3 (https=) |
| NZ (1) | NZ552027A (https=) |
| PL (1) | PL1791423T3 (https=) |
| PT (1) | PT1791423E (https=) |
| RU (1) | RU2366412C2 (https=) |
| WO (1) | WO2006022762A1 (https=) |
| ZA (1) | ZA200700694B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101682512B1 (ko) * | 2008-09-15 | 2016-12-05 | 라일라 뉴트라슈티칼스 | 보스웰리아 세라타 추출물을 포함하는 상승적인 항-염증 조성물 |
| ITVR20080125A1 (it) * | 2008-11-13 | 2010-05-14 | Phytonature Sas Di Masini Dr Antoni O E C | Nuova forma di preparazione ed utilizzo della boswellia serrata |
| RU2578025C2 (ru) * | 2010-02-15 | 2016-03-20 | Лайла Ньютрасьютикалз | Новый низкополярный экстракт камеде-смолы boswellia и его синергетические композиции |
| US20110218172A1 (en) * | 2010-03-02 | 2011-09-08 | Muhammed Majeed | Composition for down-regulating pro-inflammatory markers |
| CN102670690A (zh) * | 2011-03-14 | 2012-09-19 | 苏州博创园生物医药科技有限公司 | 一种抗牛皮癣纯天然药物乳膏及其制备方法 |
| CN102670565A (zh) * | 2011-03-14 | 2012-09-19 | 苏州博创园生物医药科技有限公司 | 一种含天然药物的透皮吸收贴片 |
| CN103193853A (zh) * | 2012-01-06 | 2013-07-10 | 苏州博创园生物医药科技有限公司 | 用于治疗银屑病的化合物、组合物及其制备方法 |
| US9498423B2 (en) * | 2012-05-07 | 2016-11-22 | Sami Labs Limited | Synergistic selenopeptide formulations for the protection of dermal papilla cells |
| JP2019513775A (ja) * | 2016-04-19 | 2019-05-30 | アズーラ オフサルミックス エルティーディー. | 角化症の処置のための組成物 |
| US9975917B1 (en) | 2017-09-20 | 2018-05-22 | King Saud University | Pentacyclic triterpenoidal derivatives |
| EP4087655A4 (en) | 2020-01-10 | 2024-02-21 | Azura Ophthalmics Ltd | INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY |
| EP4295842A1 (en) | 2022-06-24 | 2023-12-27 | Faaborg Pharma - IP ApS | A skin care composition |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3670084A (en) * | 1969-06-20 | 1972-06-13 | Leopoldo F Montes | Method of treating psoriasis with cycloheximide |
| DE4201903B4 (de) * | 1992-01-24 | 2004-04-15 | Hermann P.T. Prof. Dr.Med. Ammon | Pharmazeutische Verwendung von Boswelliasäuren |
| DE4445728A1 (de) * | 1994-12-21 | 1996-06-27 | Simmet Th Prof Dr | Verwendung von Boswelliasäure zur Behandlung von Hirntumoren |
| US5536506A (en) * | 1995-02-24 | 1996-07-16 | Sabinsa Corporation | Use of piperine to increase the bioavailability of nutritional compounds |
| RU2152218C1 (ru) * | 1998-04-21 | 2000-07-10 | Дальневосточный государственный медицинский университет | Способ лечения псориаза |
| CN1064264C (zh) * | 1998-04-28 | 2001-04-11 | 山东省滨州卫生学校 | 富硒灵芝在制备治疗银屑病的药物中的应用 |
| US6399105B1 (en) * | 1999-01-20 | 2002-06-04 | Peter Donald Collin | Sea cucumber carotenoid lipid fraction products and methods of use |
| WO2000066111A1 (en) * | 1999-04-30 | 2000-11-09 | Sabinsa Corporation | Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
| GB0230203D0 (en) * | 2002-12-27 | 2003-02-05 | Domantis Ltd | Fc fusion |
| BR0317885A (pt) * | 2002-12-30 | 2005-12-06 | Celgene Corp | Composto, isÈmeros s e r enantiomericamente puros do mesmo, composição farmacêutica e métodos de inibir pde4 e mmp, de modular a produção de tnf-alfa, de tratar ou prevenir mds, de tratar doença mieloproliferativa, angiogênese indesejada, câncer, uma doença, inflamação dos pulmões, depressão, distúrbio pulmonar obstrutivo crÈnico, doença inflamatória do intestino, dermatite atópica, psorìase, doença de crohn, artrite reumatóide, asma, eslcerose múltipla e doença cardìaca em um mamìfero e de tratar, prevenir ou controlar a sìndrome de dor regional complexa |
-
2004
- 2004-10-14 PT PT47950605T patent/PT1791423E/pt unknown
- 2004-10-14 ES ES04795060T patent/ES2422893T3/es not_active Expired - Lifetime
- 2004-10-14 AU AU2004322710A patent/AU2004322710B2/en not_active Ceased
- 2004-10-14 RU RU2007102720/14A patent/RU2366412C2/ru active
- 2004-10-14 CN CN2004800436759A patent/CN101132693B/zh not_active Expired - Fee Related
- 2004-10-14 DK DK04795060.5T patent/DK1791423T3/da active
- 2004-10-14 WO PCT/US2004/033846 patent/WO2006022762A1/en not_active Ceased
- 2004-10-14 EP EP04795060.5A patent/EP1791423B1/en not_active Expired - Lifetime
- 2004-10-14 NZ NZ552027A patent/NZ552027A/en not_active IP Right Cessation
- 2004-10-14 PL PL04795060T patent/PL1791423T3/pl unknown
- 2004-10-14 JP JP2007524780A patent/JP4820819B2/ja not_active Expired - Fee Related
-
2007
- 2007-01-25 ZA ZA200700694A patent/ZA200700694B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ552027A (en) | 2009-10-30 |
| EP1791423A1 (en) | 2007-06-06 |
| JP2008508354A (ja) | 2008-03-21 |
| JP4820819B2 (ja) | 2011-11-24 |
| RU2007102720A (ru) | 2008-09-10 |
| EP1791423A4 (en) | 2009-06-17 |
| ZA200700694B (en) | 2007-11-28 |
| WO2006022762A1 (en) | 2006-03-02 |
| AU2004322710A1 (en) | 2006-03-02 |
| ES2422893T3 (es) | 2013-09-16 |
| WO2006022762B1 (en) | 2006-05-04 |
| AU2004322710B2 (en) | 2011-03-31 |
| CN101132693B (zh) | 2012-11-07 |
| DK1791423T3 (da) | 2013-08-05 |
| CN101132693A (zh) | 2008-02-27 |
| PT1791423E (pt) | 2013-08-02 |
| EP1791423B1 (en) | 2013-05-01 |
| RU2366412C2 (ru) | 2009-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0422525D0 (en) | Dermatological compositions and methods | |
| PL1766640T3 (pl) | Kabel i sposób jego wytwarzania | |
| PL1766639T3 (pl) | Kabel i sposób jego produkcji | |
| ZA200808431B (en) | Fungicidal compositions and methods of using the same | |
| GB0718972D0 (en) | Compounds and methods of making the compounds | |
| IL176958A0 (en) | Compounds and methods of use | |
| IL183581A0 (en) | Viscosupplementation devices and compositions | |
| GB2434983B (en) | Methods and compositions for wound healing | |
| IL189795A0 (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
| EP1959929A4 (en) | COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING | |
| IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
| TWI341472B (en) | Prioritization of application component distribution | |
| ZA200805711B (en) | Solid biocidal compositions and methods of using the same | |
| IL187405A0 (en) | Methods and compositions for the treatment of pain | |
| PL1791423T3 (pl) | Kompozycje i sposoby postępowania z hiperproliferacyjnymi zaburzeniami dermatologicznymi | |
| EP1812451A4 (en) | COMPOUNDS AND METHODS OF USE THEREOF | |
| EP1912630A4 (en) | COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN | |
| IL180195A0 (en) | Aequorin-containing compositions and methods of using same | |
| GB0424051D0 (en) | Compounds and compositions | |
| GB0520930D0 (en) | Composition and method of use | |
| ZA200710476B (en) | Methods and compositions for the treatment of pain | |
| HK1099682A (zh) | 炎症治療用組合物及方法 | |
| AU2005904610A0 (en) | Pesticidal composition and method of use | |
| HK1092700A (en) | Compounds and methods of use | |
| HK1110530A (en) | Methods and compositions for the treatment of pain |